When Duke faces No. 5 Northwestern at home on Sunday, it’ll be winding back the clock: Its in-game promotion is called “Remembering the 2010s,” a decade that saw the Blue Devils advance to six straight NCAA quarterfinals and two final fours.
It’s also a decade that, especially near its end, brought a host of new challengers to the ACC. The usual suspects are still there — namely, North Carolina and Virginia, who account for all of the current ACC’s national titles and are still top 10 teams today.
But the rest of the conference is catching up. Boston College, Notre Dame and Syracuse all finished 2019 in the top 20, and Virginia Tech has seemed close to a breakout for a few seasons. And Duke has found itself struggling for a place in the national conversation.
The Blue Devils will try to start the new decade by resurrecting the early days of the last one. After two consecutive 8-9 finishes in 2017 and 2018, Duke rebounded with an 11-8 season in 2019 but still missed out on the NCAA tournament for the third year in a row. Even worse, Duke lost star attacker Charlotte North in the offseason after she transferred to Boston College. Initially ruled ineligible due to ACC transfer rules, North was granted eligibility for 2020 in October.
The schedule did the Blue Devils no favors in 2019. In their last three weeks of the regular season, Duke faced Syracuse, Boston College, Notre Dame and North Carolina and lost each contest. The Blue Devils punched back with an upset win over the Irish in the ACC tournament quarterfinals, but they couldn’t pull off a semifinal victory over the Tar Heels.
The 2020 slate is no different. In addition to its ACC opponents, the Blue Devils will also see Navy, High Point and Penn in their non-conference schedule — all teams ranked in the preseason top 20.
The Blue Devils are young. Nearly two-thirds of their players are underclassmen, and replacing the 82 goals that North brought to the offensive attack last season will be no small feat.
Their quest to reenter the national picture begins Friday against Gardner-Webb.